Roche is spending $850 million upfront to buy Regor Pharmaceuticals’ suite of next-generation CDK inhibitors as it doubles ...

Prime Medicine announced Monday morning that it is cutting its pipeline, and it signed a T cell therapy partnership with ...

As other young radiopharmaceutical companies get acquired by drugmakers, Boston-based Aktis Oncology wants to become one of ...

WeightWatchers said Friday that its CEO Sima Sistani, who shifted the weight loss giant’s strategy to prescribing obesity ...

Novo Nordisk has told government and global nonprofits that it plans to significantly downsize its manufacturing of some of ...

The federal government renewed its threats to Johnson & Johnson on Friday over the company’s proposal to change how some ...

What makes a great biotech startup? Every year, the Endpoints 11 awards try to answer that question. We've spent the last ...

Celldex Therapeutics has unveiled 52-week results from a mid-stage study of its anti-KIT drug in chronic hives, raising ...

Johnson & Johnson and Legend Biotech's CAR-T cell therapy Carvykti reduced the risk of death by 45% compared to standard of ...

Johnson & Johnson is winding down its pharma division's cardiovascular and metabolic unit, Endpoints News has learned. The ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...

Pfizer said it will withdraw its sickle cell disease treatment Oxbryta from all markets worldwide, after data showed an ...